We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

137 hedge funds and large institutions have $3.23B invested in SpringWorks Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 46

10% more funds holding

Funds holding: 124 → 137 (+13)

3% more capital invested

Capital invested by funds: $3.13B → $3.23B (+$103M)

0.72% more ownership

Funds ownership: 88.96% → 89.68% (+0.72%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
51
Reduced
46
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$95.8M
2
PA
Perceptive Advisors
New York
+$52.6M
3
Bank of America
Bank of America
North Carolina
+$38.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.4M
5
CCM
Consonance Capital Management
New York
+$24.1M

Top Sellers

Rank Fund Capital Flow
1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$114M
2
O
OrbiMed
New York
-$95.5M
3
DM
Deerfield Management
New York
-$69.3M
4
Goldman Sachs
Goldman Sachs
New York
-$16.1M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$11.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
ADIM
126
Alpha DNA Investment Management
Maryland
$12K – – –
PHK
127
Point72 Hong Kong
Hong Kong
$10K -$22.8K -291 -69%
EVM
128
Eaton Vance Management
Massachusetts
$10K +$11.1K +142 New
Daiwa Securities Group
129
Daiwa Securities Group
Japan
$7K – – –
LC
130
Lindbrook Capital
California
$7K +$7.83K +100 New
CAPTRUST Financial Advisors
131
CAPTRUST Financial Advisors
North Carolina
$3K +$2.66K +34 New
TWA
132
TCI Wealth Advisors
Arizona
$3K +$2.9K +37 New
PNC Financial Services Group
133
PNC Financial Services Group
Pennsylvania
$2K +$313 +4 +24%
US Bancorp
134
US Bancorp
Minnesota
$2K +$2.43K +31 New
AIG
135
American International Group
New York
$1.03K +$2.9K +37 +0.3%
Nisa Investment Advisors
136
Nisa Investment Advisors
Missouri
$110 – – –
Lord, Abbett & Co
137
Lord, Abbett & Co
New Jersey
– -$3.05M -42,032 Closed
AC
138
Athanor Capital
New York
– -$1.27M -17,489 Closed
Jacobs Levy Equity Management
139
Jacobs Levy Equity Management
New Jersey
– -$750K -10,339 Closed
FC
140
FORA Capital
Florida
– -$377K -5,197 Closed
BAM
141
Blueshift Asset Management
New Jersey
– -$348K -4,801 Closed
ECM
142
ExodusPoint Capital Management
New York
– -$264K -3,634 Closed
Arrowstreet Capital
143
Arrowstreet Capital
Massachusetts
– -$239K -3,300 Closed
Handelsbanken Fonder
144
Handelsbanken Fonder
Sweden
– -$239K -3,300 Closed
Truist Financial
145
Truist Financial
North Carolina
– -$231K -3,188 Closed
PFO
146
Pathstone Family Office
New Jersey
– -$73K -1,000 Closed
QT
147
Quantbot Technologies
New York
– -$7K -100 Closed
BI
148
BVF Inc
California
– -$4K -50 Closed
2 3 4 5
6

SWTX Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2021, worth a combined $3.23B — up 3.3% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $95.8M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $114M.

  • 137 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2021, up from 124 in Q4 2020.
  • Funds reported $3.23B of SpringWorks Therapeutics stock for Q1 2021, up 3.3% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q1 2021 and 12 closed out, a net change of +13 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $95.8M added.
  • The largest SpringWorks Therapeutics seller in Q1 2021 was Bain Capital Life Sciences Investors, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2021.